Roberto Maria Antonio DI MARCO
Keywords
Urinary infections, host-microbiota interaction, bacterial pathogenesis, skin microbiome, gut microbiome, Dysbiosis, vector-borne disease, Autoimmunity
Current academic position: University of Catania, Italy
Full Professor of Microbiology and Clinical Microbiology at the Department of Pharmaceutical and Health Sciences (DSFS) of the University of Catania
Previous academic position: University of Molise - Campobasso, Italy
2022 – 2024 Full Professor of Microbiology and Clinical Microbiology
2005 – 2022 Associate Professor of Microbiology and Clinical Microbiology
at the Department of Medicine and Health Sciences "V. Tiberio" (DiMES) of the University of Molise
Previous academic appointments:
2023 – 2024 Director of the Postgraduate School of Medical Microbiology and Virology
2017 – 2023 President of the Master's Degree Course in Nursing and Midwifery Sciences
2016 – 2017 Director of the Master in Family Nursing
2011 – 2023 President of the Degree Course in Nursing
2005 – 2024 Head of the Clinical Microbiology Laboratory DiMES Department
2005 – Present Member of the Board of the PhD in Translational Medicine
Other current assignments/tasks
Member of the editorial board/reviewer of over 20 journals (microbiology and immunology)
Reviewer for national and international grant/research programs
Scientific advice from several international pharmaceutical companies
Co-founder, partner and scientific referent of the SPIN-OFF "Natival SRL", a company incubated at the University of Molise
Co-founder, partner and scientific referent of the SPIN-OFF "PHARMAMOL SRL", a company incubated at the University of Molise
CV Studiorum
1984 – 1990 Degree in Medicine and Surgery, University of Catania
1991 – 1994 Specialization in Microbiology and Virology University of Catania
1995 – 1999 PhD in Microbiological Sciences University of Milan
2000 – 2005 Specialization/residency in Clinical Pathology University of Catania
Other educational experiences
2007 –2011 Head of the Laboratory of Molecular Neurobiology- Neuromed Pozzilli (IS)
1996-1998 Research scientist At Neurobiology Unit -Karolinska Institutet Stockholm, Sweden
1993 – 1994 Research scientist at Medical Immunology Lab - University of Copenhagen - Rigshospitalet, Denmark
1991 Visiting Scientist Institute of Microbiology University of Turin (Italy)
1990 Visiting Student Infection Disease dep University of Sarajevo
Publications and bibliography
https://orcid.org/0000-0001-5075-4597
https://www.researchgate.net/profile/Roberto-Di-Marco-3/research
https://loop.frontiersin.org/people/321223/overview
https://www.scopus.com/authid/detail.uri?authorId=7004894526
https://www.webofscience.com/wos/author/record/G-7765-2012
Patents
|
Bacterial cell wall bound to a mucopolysaccharide, uses thereof and process for …
|
WO2022243558A8 |
WO |
2023-01-12 |
|
Cutibacterium acnes strain and its medical uses
|
BR112022015153A2 |
WO EP CN KR AU BR CA CO IL IT |
2022-10-11
|
|
Ceppo batterico e suoi usi medici
|
IT202000003233A1 |
WO EP CN KR AU BR CA CO IL |
2021-08-18 |
|
Method for detecting the presence and quantity of the lrp8 receptor and of its …
|
WO2020136546A1 |
WO EP US IT |
2020-07-02 |
|
Composition for the prevention or treatment of polycystic ovary syndrome and …
|
PT3165229T |
EP DK ES HR HU IT LT PL PT RS SI TR |
2019-05-28 |
|
Composition for the prevention and treatment of acute and recurrent urinary …
|
EP2895180A1 |
WO EP ES HU PL PT |
2015-07-22 |
Research interest:
The research interest of Prof Roberto Di Marco gravitates around the broad theme of host-parasite interaction, ranging in the consequential applications. A multidisciplinary vision and approach characterize his activity. For this reason, developed and set up pre-clinical models in vitro (microbial/cell culture) or in vivo (rodents) to study mechanisms of immunity, autoimmunity, host-microbiota interaction, and drug development. As part of the translational research activity, he also developed and validated "alternative" animal models (insects, gastropods) valid for the first step of screening new substances or extracts from botanical potentially used for therapeutic applications. More recently, thanks to several transcontinental collaborations and opportunities, he is starting to build a network for deepening the mechanism of pathogenesis of emerging vector-borne diseases.